Results 211 to 220 of about 877,222 (332)

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Determining acoustic impedance cube by inverting seismic data using feedforward and radial basis neural networks in an Iranian oilfield. [PDF]

Sci Rep
Ghiasvand A, Javaherian A, Amirmazlaghani M, Saberi MR, Mahdavi Basir H, Khadem B.   +5 more
europepmc   +1 more source

Impedance [PDF]

Transactions of the American Institute of Electrical Engineers, 1893
openaire   +1 more source

Evaluation of body composition in patients with Type 1 diabetes mellitus using bioelectric impedance

, 2017
Janja Musulin, Maja Baretić, Vesna Šimegi-Đekić   +2 more
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Adaptive variable impedance hybrid force-position control method for hub-spoke grinding robots. [PDF]

Sci Rep
Wei S, Ze-Jian Z, Hao-Yu Y, Xiao-Hong D, Jia-Yu S, Ting G, Jun P, Jia A.   +7 more
europepmc   +1 more source

The influence of BMI on optimal PEEP titrated by electrical impedance tomography in ARDS patients [PDF]

Yutong Zhao, Yi Chi, Siyi Yuan, Yelin Gao, Jin Yang, Meng Zhang, Mengru Xu, Qianlin Wang, Xiaotong Sun, Jingbing Han, Inéz Frerichs, Zhanqi Zhao, Jing Jiang, Huaiwu He, Yun Long   +14 more
openalex   +1 more source

Hazelnut Pollen Phenotyping Using Label-Free Impedance Flow Cytometry

, 2020
Lorenzo Ascari, V. Cristofori, Federico Macrì, Roberto Botta, Cristian Silvestri, Tommaso De Gregorio, Eloy Suarez Huerta, Marco Di Berardino, Silvan Kaufmann, Consolata Siniscalco   +9 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source